about
Posterior fossa involvement in the diagnosis of adult-onset inherited leukoencephalopathies.High CD3+ Cells in Intracranial Thrombi Represent a Biomarker of Atherothrombotic Stroke.Brain Calcifications in Adult-Onset Genetic Leukoencephalopathies: A Review.Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.Mini-Exome Coupled to Read-Depth Based Copy Number Variation Analysis in Patients with Inherited Ataxias.Endovascular Management of Tandem Occlusion Stroke Related to Internal Carotid Artery Dissection Using a Distal to Proximal Approach: Insight from the RECOST Study.Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.Cognitive Impairment and Basal Ganglia Functional Connectivity in Vascular Parkinsonism.A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy.[Symptomatic giant Virchow-Robin spaces].Focal CIDP presenting as chronic progressive monomelic sensory neuropathy.Adult-onset cerebral X-linked adrenoleukodystrophy with major contrast-enhancement mimicking acquired disease.COL4A1 mutation revealed by an isolated brain hemorrhage.Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification.Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.Mechanical Thrombectomy for Minor and Mild Stroke Patients Harboring Large Vessel Occlusion in the Anterior Circulation: A Multicenter Cohort Study.Psychological processes associated with insomnia in patients with multiple sclerosis.Is impaired cerebral vasoreactivity an early marker of cognitive decline in multiple sclerosis patients?Low Signals on T2* and SWI Sequences in Patients with MS with Progressive Multifocal Leukoencephalopathy.Favorable Bridging Therapy Based on DWI-FLAIR Mismatch in Patients with Unclear-Onset Stroke.Favorable revascularization therapy in patients with ASPECTS ≤ 5 on DWI in anterior circulation stroke.Quantitative susceptibility mapping in superficial hemosiderosis of the central nervous system.A Case Report of Solitary Sclerosis: This is Really Multiple Sclerosis.MRI volumetric morphometry in vascular parkinsonism.CSF1R-related leukoencephalopathy mimicking primary progressive multiple sclerosis.Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.A novel autosomal dominant leukodystrophy with specific MRI pattern.Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France.Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.The wide POLG-related spectrum: An integrated view.Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects.Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.MRI pattern approach of adult-onset inherited leukoencephalopathies.Late diagnosis of COL4A1 mutation and problematic vascular risk factor management.Sensitivity of [18F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.Primary brain calcification: an international study reporting novel variants and associated phenotypesAdult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect
P50
Q31087193-B6210AF3-5425-4B83-931C-C286FCDA73E2Q36010610-905AC9C6-2E21-4A5B-B59A-964C4CEE7F15Q36409313-8239EA25-062E-4A5D-8174-B6D6EBC9A751Q37680004-99E10351-5261-4BD2-9F50-632B08A9BF1AQ39486694-F6F492B0-1904-4E2B-AAEE-0537ECB9F84BQ39930533-28DC5C51-C399-4451-86C4-36AB3B31F872Q40117554-812FD76D-1695-4C5B-9914-D50DB71DA494Q40421787-536DE4B3-A95B-49FD-A86B-F744DA31DE7DQ42496308-4417D604-322A-4D51-88DF-EB460D986352Q43078170-04D0C9E0-6799-4766-A3C5-B5D71EED55AEQ44349457-DDD76475-09A2-46F2-9A6D-6803E91E9271Q44496740-FAAC31E1-CE67-46E3-BBA6-5D0D23B3887EQ45021127-3F84B8F7-83C2-40B0-BA16-997712E512C8Q45324066-4DB6CDD6-C243-405E-8A05-61C19EF07885Q45750904-6AC446B0-13D2-416A-9351-B3195C4C6636Q46388185-4D769308-1942-47C5-827C-6C727A574663Q47288867-595CE410-E1D0-4073-AEDE-36DB59B50F1AQ47580712-912096AF-DC6E-409B-8BD5-7722E62E580DQ47648042-CC2420D8-589A-4DB1-866D-F3160FC6407FQ48021241-595AD6F4-97FC-4099-98A2-5FA2269BD0C2Q48094258-726A6C45-8A11-4F35-BB31-6AB529C213BDQ48108534-118636B8-640E-48D9-B638-9C338B2D8208Q48111706-1D01FCF8-4E40-4100-8B0B-46F1BCD8660DQ48138571-EFAC2AC4-3D5E-4AFA-95FA-813312734255Q48140531-1246D7E5-C2EE-433D-BB23-7234BB2125CBQ48189178-24493E1A-F55D-44F5-9D00-EBE3B6CE6E1FQ48195047-E4287310-85A8-4D35-91E8-6932793E9B3FQ48200023-000CB669-C7F0-4853-888B-85616F586FCEQ48327770-71D73BE4-B7DF-49D6-8A4E-928F5FE8B1C7Q48340430-412874EB-1A91-41D5-91A3-C2B71866E1C9Q48404952-6DEBD6B1-50B8-43FC-A09E-1F0EB78EC2F6Q48563779-26685985-C9B3-488B-AD70-D8C8D6467E29Q48586701-100F8D2B-8655-4AB7-B4A5-8F726216DA09Q48774607-E9F71181-81C9-454A-9ED6-1240FF4604B3Q49055426-662B5A73-771E-470C-BDE9-832993D4DB33Q50357305-A4FD81D4-35F6-489A-BD26-23663CA9020BQ50783839-39D47DCE-55CF-40B5-A03D-BA0793EF70B5Q53062541-E5A0696C-6C5A-4334-9C4E-33A447DCBD60Q56930830-BF709621-4CE2-4F2D-A67B-8DC6A69F8552Q57061194-9BC293CB-C5D1-4874-928D-5DC8D0AD85AF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Xavier Ayrignac
@ast
Xavier Ayrignac
@en
Xavier Ayrignac
@es
Xavier Ayrignac
@nl
type
label
Xavier Ayrignac
@ast
Xavier Ayrignac
@en
Xavier Ayrignac
@es
Xavier Ayrignac
@nl
prefLabel
Xavier Ayrignac
@ast
Xavier Ayrignac
@en
Xavier Ayrignac
@es
Xavier Ayrignac
@nl
P106
P21
P31
P496
0000-0003-3834-2981